Slate Bio
Latest round
- Seed
Last raised
- Jan 2021
Total raised
- $1.8M
Investors
- 5
About Slate Bio
Slate Bio, Inc.Founded in 2020 and headquartered in Charlottesville, US, Slate Bio, Inc. specializes in T regulatory therapies to address autoimmune diseases.35 mn.Slate Bio, Inc. specializes in advanced T regulatory (T reg) therapies designed to address autoimmune diseases. The company's core offerings focus on restoring immune balance and promoting tolerance to self-antigens, ultimately aiming to reduce the symptoms and progression of autoimmune disorders. Slate Bio’s therapies are engineered to target specific pathways involved in immune dysregulation, making them suitable for a range of conditions. These products are primarily marketed to healthcare providers and institutions involved in treating patients with autoimmune diseases, including hospitals, specialized clinics, and research facilities.Slate Bio generates revenue through direct partnerships with healthcare providers and institutions, leveraging a business-to-business (B2B) model. This structure allows the company to supply its T reg therapies to hospitals and clinics that treat patients with autoimmune conditions. Transactions typically occur on a contractual basis, where healthcare providers order products for use in treatment protocols and clinical research. Pricing structures for these proprietary therapies are aligned with industry standards for similar medical advancements, reflecting the innovative nature of the products.In December 2022, Slate Bio, Inc. The company plans to launch additional products designed specifically for various autoimmune diseases by 2024. Furthermore, Slate Bio aims to expand into new geographic markets, specifically targeting Asia and additional regions in Europe by late 2024 to meet the growing demand for effective autoimmune disease therapies.
Who invested in Slate Bio
5 investors across 1 round
See all investors in Slate Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 19, 2021
Amount
$1.8M
Investors
Questions about Slate Bio
Who invested in Slate Bio?
Slate Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Slate Bio raised?
Slate Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Slate Bio last raise money?
Slate Bio's most recent round on record is a Seed, in Jan 2021.
What does Slate Bio do?
Slate Bio is a biotechnology company.
Where is Slate Bio headquartered?
Slate Bio is headquartered in Charlottesville, US.
Which VCs invest in companies like Slate Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Slate Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Slate Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.